In July we were able to ward this off but now its has come around. January 1st of 2013 the lockup will allow for more than two-thirds of the company's shares owned by executives, management and directors to be available for sale. Any thoughts? Dilution?
"Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), reports that Dr. David Bar-Or, Ampio's Founder, Chief Scientific Officer and largest shareholder, and Michael Macaluso, Ampio's CEO, Chairman and Lead Investor, have extended their July 15th 2012 lock-up agreement until January of 2013. This extended lockup encompasses more than two-thirds of the company's shares owned by executives,
management and directors."
If you were an executive, would you sell at these prices or wait till there's a breakthrough? Unless someone is is need of money, I don't see this expiration affecting anything. These guys are there to make money so unless there's something wrong with the company, they won't sell. If however, we see that execs are selling massively (extremely unlikely), then you'll know what to do.
I was thinking the same but then I thought capital gains reasons, and who knows maybe for personal gains. Another thought is that you also need to think these execs didn't buy the stock today they probably have stock at the price of $1-3, which translates into big money at these prices.
Everyone has known about the expiration for a long time. Stock price today gives you the answer - up over 8%! Shorts are running for cover on HUGE volume!! Do you think Mac just hired a new CEO so they could sell their stock at these prices?? They clearly see a triple - or more - as soon as even ONE drug passes and hits the market!! All you need do is see what similar companies have done when they get FDA approval.